Literature DB >> 2109330

Specific sensitivity of patients with panic attacks to carbon dioxide inhalation.

E Griez1, C de Loof, H Pols, J Zandbergen, H Lousberg.   

Abstract

One inhalation of 35% CO2 in oxygen was administered to 36 patients with anxiety disorders and 14 healthy controls. Eighteen patients had a diagnosis of panic disorder (PD) and 18 of obsessive-compulsive disorder (OCD). As a placebo control for CO2, compressed air was administered in a double-blind design. Immediately before and after the inhalation, levels of anxiety and DSM-III-R symptoms of panic were assessed. CO2 elicited high levels of subjective anxiety in the PD group. Patients with OCD were hardly affected by the inhalation, and did not differ from healthy controls. These results suggest that CO2 challenge should be considered as a specific probe for subjects with panic-anxiety. It is speculated that CO2 may trigger some as yet undefined mechanisms, possibly linked to ventilation control, which demarcate panic from other types of pathological anxiety.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109330     DOI: 10.1016/0165-1781(90)90121-k

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  10 in total

1.  Temporal stability of multiple response systems to 7.5% carbon dioxide challenge.

Authors:  Roxann Roberson-Nay; Eugenia I Gorlin; Jessica R Beadel; Therese Cash; Scott Vrana; Bethany A Teachman
Journal:  Biol Psychol       Date:  2017-02-02       Impact factor: 3.251

2.  Clinical characteristics of latent classes of CO2 hypersensitivity in adolescents and young adults.

Authors:  Lance M Rappaport; Christina Sheerin; Jeanne E Savage; John M Hettema; Roxann Roberson-Nay
Journal:  Behav Res Ther       Date:  2017-03-30

3.  Examining the latent class structure of CO2 hypersensitivity using time course trajectories of panic response systems.

Authors:  Roxann Roberson-Nay; Jessica R Beadel; Eugenia I Gorlin; Shawn J Latendresse; Bethany A Teachman
Journal:  J Behav Ther Exp Psychiatry       Date:  2014-11-15

4.  Validation of candidate anxiety disorder genes using a carbon dioxide challenge task.

Authors:  Jeanne E Savage; Omari McMichael; Eugenia I Gorlin; Jessica R Beadel; Bethany Teachman; Vladimir I Vladimirov; John M Hettema; Roxann Roberson-Nay
Journal:  Biol Psychol       Date:  2015-04-22       Impact factor: 3.251

5.  Evidence for distinct genetic effects associated with response to 35% CO₂.

Authors:  Roxann Roberson-Nay; Sara Moruzzi; Anna Ogliari; Elettra Pezzica; Kristian Tambs; Kenneth S Kendler; Marco Battaglia
Journal:  Depress Anxiety       Date:  2013-01-24       Impact factor: 6.505

6.  Yohimbine premedication and 35% CO2 vulnerability in healthy volunteers.

Authors:  H Pols; E Griez; K Verburg; D van der Werf
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

7.  Respiratory, autonomic, and experiential responses to repeated inhalations of 20% CO₂ enriched air in panic disorder, social phobia, and healthy controls.

Authors:  Jens Blechert; Frank H Wilhelm; Alicia E Meuret; Eva M Wilhelm; Walton T Roth
Journal:  Biol Psychol       Date:  2010-01-12       Impact factor: 3.251

8.  CO2 exposure as translational cross-species experimental model for panic.

Authors:  N K Leibold; D L A van den Hove; W Viechtbauer; G F Buchanan; L Goossens; I Lange; I Knuts; K P Lesch; H W M Steinbusch; K R J Schruers
Journal:  Transl Psychiatry       Date:  2016-09-06       Impact factor: 6.222

9.  Carbon dioxide inhalation induces dose-dependent and age-related negative affectivity.

Authors:  Eric J Griez; Alessandro Colasanti; Rob van Diest; Ewa Salamon; Koen Schruers
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240

10.  Brain Circulation during Panic Attack: A Transcranial Doppler Study with Clomipramine Challenge.

Authors:  Francesco Rotella; Marinella Marinoni; Francesca Lejeune; Fabiana Alari; Daniela Depinesi; Fiammetta Cosci; Carlo Faravelli
Journal:  Psychiatry J       Date:  2014-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.